ESMO 2022: Updates in Colorectal Cancer

The European Society for Medical Oncology Annual Meeting 2022 brought together thousands of experts in oncology to hear new data and discuss how to improve the diagnosis and treatment of patients with cancer. In this podcast, we hear from some of the leading experts in colorectal cancer, as they discuss the biggest trials and hot topics from the meeting. Dr Sartore-Bianchi discusses overcoming acquired resistance to targeted therapy in colorectal cancer, and Dr Cremolini talks on the influence of sidedness on prognosis and treatment of metastatic colorectal cancer. Dr Fang discusses EpCAM-targeted CAR T-cell therapy for advanced colorectal cancer and Dr Cohen provides real-world evidence on ctDNA reliably predicting recurrence in resected colorectal cancer. We also hear from Prof. Stintzing, Prof. Strickler and Dr Orlandi on some key colorectal cancer trial data presented at the meeting.